3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Desmoid Tumors
1
Interventions
pembrolizumab
2
reducing agent and tunicamycin-responsive protein, human
1
olutasidenib
1
epacadostat
1
ebselen
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
decitabine and cedazuridine drug combination
1
daratumumab
1
carfilzomib
1
auricularum
1
Vorinostat
1
Surveys and Questionnaires
1
Specimen Handling
1
Magnetic Resonance Spectroscopy
1
Kidney Transplantation
1
Immunotherapy, Adoptive
1
Immunoglobulin G
1
Hyaluronoglucosaminidase
1
Fluorodeoxyglucose F18
1
Electrochemotherapy
1
Dexamethasone
1
Continuous Positive Airway Pressure
1
Cell- and Tissue-Based Therapy
1
Calcium Dobesilate
1
Bleomycin
1
Biopsy
1
A-dmDT390-bisFv(UCHT1) protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Bleomycin
×
30 days
×
Clear all
NCT06660121
2026-05-14
ECT-DESMO
Istituto Ortopedico Rizzoli
Withdrawn